News Focus
News Focus
Post# of 257259
Next 10
Followers 842
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 211354

Tuesday, 05/16/2017 8:51:43 PM

Tuesday, May 16, 2017 8:51:43 PM

Post# of 257259
CHRS’s PR on Humira-IPR ruling:

https://finance.yahoo.com/news/coherus-biosciences-prevails-135-ipr-232917061.html

The PTAB’s decision invalidates all claims of the patent that were directed to a method for treating rheumatoid arthritis by administering 40 mg of HUMIRA subcutaneously every 13 to 15 days.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now